EyePoint Pharmaceuticals, Inc. MOUs
1 Contracts & Agreements
- Memorandum of Understanding, dated August 26, 2024, by and between EyePoint Pharmaceuticals, Inc. and Ocumension Therapeutics (Filed With SEC on November 7, 2024)
